TCL Archive Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited May 28, 1976
TCL Archive JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials November 19, 2010
TCL Archive Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis December 30, 2011
TCL Archive NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned. July 16, 2004
